ArticleMaterials today. Bio2025

FMRP silencing via siRNA lipid nanoparticles to reprogram the tumor microenvironment and enhance anti-PD-1 efficacy in triple-negative breast cancer.

Letian Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.